Association Between the Hepatic Steatosis Index and Risk of Incident Type 2 Diabetes Mellitus in the Normoglycemic Population:A Longitudinal Prospective Study in Japan
DOI: https://doi.org/10.2147/dmso.s462459
2024-06-08
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Rite Si, 1, 2, &ast Jingyi Xiao, 2, &ast Keyang Zheng, 3 Yuzhe Yin, 2 Yamin Li 1 1 Emergency Intensive Care Unit, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China; 2 Sixth Clinical Medical School, Capital Medical University, Beijing, People's Republic of China; 3 Center of Hypertension, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yamin Li, Email Purpose: The Hepatic Steatosis Index (HSI) is a reliable predictor of non-alcoholic fatty liver disease (NAFLD), which can increase the risk of type 2 diabetes mellitus (T2DM). However, limited research has directly predicted HSI's association with T2DM occurrence at normal blood glucose levels. Hence, this study aimed to assess the link between baseline HSI and T2DM development under euglycemic conditions while also exploring potential sex differences. Methods: Using data from the NAGALA cohort study, a Cox regression model analyzed the relationship between HSI and T2DM risk, calculating hazard ratios (HR) and 95% confidence intervals (CI). Subgroup analyses were conducted to investigate factors influencing HSI's prediction of incident T2DM. Results: During a mean 6.1-year follow-up, 238 individuals (1.65% of participants) developed T2DM. After adjusting for age, ethanol consumption, smoking status, SBP, DBP, TG, and TC, HSI showed a significant association with incident T2DM in individuals with normal glucose levels, consistent across sexes. Compared to the lowest quartile group (Q1), the HR and 95% CI for Q2, Q3, and Q4 were 1.09 (0.61, 1.93), 1.16 (0.68, 1.98), and 3.30 (2.04, 5.33), respectively (P for trend < 0.001). Subgroup analysis indicated that elevated HSI significantly increased the risk of incident T2DM in individuals with normal TG levels (P for interaction = 0.0170). Conclusion: This study highlights the significant association between elevated HSI levels and the likelihood of developing incident T2DM in individuals with normal glucose levels. Furthermore, it offers a simple and valuable screening tool for predicting T2DM. Keywords: Type 2 Diabetes Mellitus, hepatic steatosis index, Non-alcoholic fatty liver disease, risk prediction, longitudinal study Diabetes mellitus, a metabolic disorder characterized by elevated blood glucose levels, is one of the most prevalent chronic metabolic diseases. 1 Type 2 Diabetes Mellitus (T2DM), in particular, accounts for 90% of all diabetes cases. 2 Annually, over a million people succumb to diabetes, ranking it as the ninth leading cause of death. 3 The cost of diabetes care surpasses per capita healthcare expenditure by a minimum of 3.2 times, escalating to 9.4 times when complications arise. 4 T2DM is acknowledged as a significant public health concern, exerting a profound impact on both human lives and healthcare expenses. The diagnosis and prediction of T2DM involve the utilization of various indicators, as recognized by the American Diabetes Association. These indicators include fasting plasma glucose (FPG), glycated hemoglobin (HbA1c) testing, and oral glucose tolerance testing (OGTT). 5 However, research has shown that individuals who have normal levels of these indicators still face the risk of developing T2DM. 6,7 For individuals with normal values of traditional markers such as FPG and HbA1c, the risk of T2DM cannot be accurately predicted or intervened early using these conventional indicators, leading to an overlooked risk of developing T2DM. Therefore, identifying an effective predictive marker for individuals with normal blood glucose levels is of significant clinical value and urgently needed. Existing research suggests that non-alcoholic fatty liver disease (NAFLD) increases the risk of developing T2DM. 8 Several factors, including the alanine transaminase-to-aspartate aminotransferase ratio (ALT/AST), sex, and body mass index (BMI), have been identified as indicators associated with the onset of NAFLD. 9 A composite index called the Hepatic Steatosis Index (HSI), which incorporates these three factors, has been found to reliably predict NAFLD in previous studies. 10 Insulin resistance and metabolic syndrome are also risk factors for T2DM, and the literature shows a strong correlation between HSI and these conditions. 11–13 However, limited research exists on using HSI to directly predict incident T2DM, and the existing studies only include individuals with pre-diabetes, which could potentially confound the accuracy of prediction.<su -Abstract Truncated-
endocrinology & metabolism